Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/22/4/808/571195/mdq466.pdf
Reference21 articles.
1. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I;Krege;Eur Urol,2008
2. Initial versus recent outcomes with a non-risk adapted surveillance policy in stage I non-seminomatous germ cell tumors (NSGCT);Duran;J Clin Oncol,2007
3. Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy;Kollmannsberger;Ann Oncol,2009
4. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II;Krege;Eur Urol,2008
5. The changing presentation of germ cell tumours of the testis between 1983 and 2002;Powles;BJU Int,2005
Cited by 77 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Stadium IIA/B-seminoma testis: retroperitoneale lymfeklierdissectie als alternatief voor chemotherapie en radiotherapie?;Tijdschrift voor Urologie;2023-08-24
2. Exceedingly Rare Bilateral Synchronous Germ Cell Testicular Tumors With Different Histopathological Features;Cureus;2023-07-24
3. Revisiting Treatment Protocols for Stage I Testicular Seminoma: A SEER-Based Analysis;Urologia Internationalis;2023
4. Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial;The Lancet Oncology;2022-11
5. Surveillance versus Adjuvant Treatment with Chemotherapy or Radiotherapy for Stage I Seminoma: A Systematic Review and Meta-Analysis According to EAU COVID-19 Recommendations;Medicina;2022-10-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3